The new research focused specifically on associations between background parenchymal enhancement—a known risk factor for breast cancer, visualized on surveillance MRI exams—and secondary breast cancers.

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected. 

A fully automated body composition analysis derived from CT imaging can be a valuable pretreatment tool for patients with colorectal cancer. 

In a close collaboration with radiation oncologists, experts trained their model on the CT lung images of 787 patients and tested it on the scans of more than 1,300 patients from external datasets.

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

When applied to MRI and clinical features, different machine learning models were recently shown to reliably predict post-treatment recurrences of hepatocellular carcinoma. 

The new findings findings represent “a step toward improved tumor diagnoses," according to authors of a new study published in JAMA.